Medifast 2026 Q3 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Third-quarter 2026 revenue was $72 million, down 19.4% year over year, primarily due to fewer active earning coaches.
- Medifast ended the quarter with approximately 10,200 active earning coaches, compared with 19,500 in the third quarter of 2025.
- Average revenue per active earning coach was $7,064, up 54.1% year over year, while coach productivity improved year over year for the fourth consecutive quarter to 54% in Q3 and grew an estimated 8% sequentially.
- Gross profit was $50 million, down 19.5% year over year, and gross profit margin was 69.5% in both the current and prior period.
- On a non-GAAP adjusted basis, gross profit decreased 16.9% to $51.7 million, and gross margin increased 220 basis points to 71.7%.
- SG&A expense increased 4.8% year over year to $69.4 million, primarily reflecting $13.8 million of Catalyst restructuring charges.
- On a non-GAAP adjusted basis, SG&A decreased 16% to $55.6 million, while SG&A as a percentage of revenue increased 310 basis points to 77.2%.
- Operating loss was $19.4 million, compared with $4.1 million in the year-earlier period; on a non-GAAP adjusted basis, operating loss improved 3.2% to $4 million.
- Net loss was $17.5 million, or $1.57 per diluted share, compared with $2.3 million, or $0.21 per share, in the year-earlier period.
- Adjusted net loss was $2.1 million, or $0.19 per diluted share; adjusted EBITDA excluding stock-based compensation and Catalyst charges increased 29.7% to $0.4 million, and adjusted EBITDA excluding interest income increased 9.7% to $1.9 million.
- Medifast ended September 30, 2026 with $172.5 million in cash, cash equivalents, and investments and no debt; Nick Johnson also cited $173 million in cash and investments.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Greetings. Welcome to Medifast's third quarter 2026 earnings conference call. At this time, all participants are in listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero from your telephone keypad. Please note this conference is being recorded. At this time, I'll turn the conference over to Matt Daryman, Manager of Investor Relations. Thank you, Matt. You may now begin.
Good morning, and welcome to Medifast's third quarter 2026 earnings conference call. On the call with me today are Nick Johnson, Chief Executive Officer, and Jim Maloney, Chief Financial Officer. By now, everyone should have access to the earnings release for the third quarter ended September 30, 2026 that went out this morning at approximately 8:05 A.M. Eastern Time. If you have not received the release, it is available on the investor relations portion of Medifast's website at www.medifastinc.com. This call is being webcast, and a replay will also be available on the company's website. Before we begin, we would like to remind everyone that today's prepared remarks contain forward-looking statements, and management may make additional forward-looking statements in response to your questions. The words believe, expect, anticipate, and other similar expressions generally identify forward-looking statements.
These statements do not guarantee future performance, and therefore undue reliance should not be placed on them. Actual results could differ materially from those projected in any forward-looking statements. All of the forward-looking statements contained herein speak only as of the date of this call. Medifast assumes no obligation to update any forward-looking statements that may be made in today's release or call. Now, I would like to turn the call over to Medifast's Chief Executive Officer, Nick Johnson.
Thanks, Matt, and good morning, everyone. Thanks for joining us on the call today and for your continued interest in Medifast. Our third quarter was all about execution. With our new brand, Trilivy, now live, new products available, and an enhanced compensation plan and unified coach training platform launched, our 3.0 business is rolling out. Early results are already showing up in the field. We delivered revenue in line with guidance at $72 million, continuing the trend of stabilizing revenue around $75 million for the fourth consecutive quarter, and coach productivity continues to improve. We believe these trends leave us well-positioned to deliver profitability in the fourth quarter. We ended the quarter with $173 million in cash and investments and no debt, and our enterprise value continues to sit below the value of our cash and investments.
A debt-free balance sheet and a leaner cost structure give us a stable base from which to grow and invest in initiatives that can help deliver scale and profitability. Trilivy is differentiating Medifast in a large and growing metabolic health market, a market that we believe our coaches are well-positioned to own. Over the past few months, we launched the Medifast Metabolic Health Institute, introduced our MetaVantage technology ingredient platform, and brought new products and trainings to market that are designed to give us a solid foundation to deliver for clients in the metabolic health category. The brand marks the latest step in our transition from a weight loss company to a metabolic health business, where weight loss is just one outcome of better overall metabolic health. Weight loss remains important, but the quality of the weight lost matters more than ever.
That means preserving lean mass, protecting muscle, and over time, building it. Our three-phase metabolic health system is designed to deliver those outcomes, starting with Reset as the first phase. Our 10-year growth strategy is a roadmap that is designed to expand what we offer coaches and clients within a comprehensive metabolic health system. We are still at the start of that journey, but with our major launches now in market, we are shifting our focus to getting the best possible return out of what we have built. Whether we are talking to investors, coaches, or employees, I consistently emphasize how we are building our 3.0 organization around four core tenets: speed, simplicity, scale, and stewardship. Each of these showed up across our business in concrete ways this quarter. Speed is evident in the pace of the launches we've brought to market this year.
We took Reset Fuelings from an employee and coach pilot in the spring to having products available for coaches and clients by August, with all SKUs expected to be converted to the new Reset Fuelings by the end of Q4. We also introduced our new compensation plan and product line within days of each other. We have to make decisions quickly and move resources toward the areas that we believe can best drive growth and do that on a consistent and effective basis. Simplicity is at the heart of the new compensation plan and the new unified training system called the Trilivy Business Blueprint. The new compensation plan simplifies the structure of our coach organization, rewards coach productivity, and streamlines how coaches advance through the plan. The Trilivy Business Blueprint consists of the six fundamental skill sets every coach needs to build their business.
By focusing on these six core fundamentals, we reduce low value-add administrative tasks, which allows coaches to focus their energy on activities that fuel the flywheel. Namely, consistent client acquisition, quality client support, and sponsoring new coaches. An example of our commitment to scaling is the Coach Hub. The Coach Hub, created by a group of our top field leaders, is where coaches go to learn how to put those six fundamental skill sets into practice with everything they need housed in one place. Alongside this, our Trilivy Coach Certification sets a consistent standard of knowledge across the field. When coaches increase their productivity and reach the rank of Executive Director, then sponsor new coaches and teach them to do the same, we fuel the flywheel that grows our business.
Finally, stewardship is our commitment to making sure that we are providing coaches with an environment in which they can grow their businesses over the long term while also being profitable as a business. That means holding firm on cost while protecting the capabilities that drive growth. This is the principle behind Catalyst, which I will speak more about in a moment. On the whole, the indicators we are seeing in our business right now are those that have historically come before coach growth and revenue growth. Coach productivity improved year-over-year for the fourth consecutive quarter to 54% in Q3 and grew an estimated 8% sequentially, and we expect that trend to continue through the rest of 2026. The percentage of active earning coaches at Executive Director rank or above rose both year-over-year and sequentially.
Retention among Premier+ clients from the first to the second month has stabilized, with September coming in 6 percentage points higher than Premier. Our enhanced compensation plan was designed to accelerate this kind of leadership development, and we are encouraged by what we have seen in the first 2 months since launch. While these results are promising and represent historical indicators of growth, the total number of active earning coaches remains below last year's level, and we expect that trend to continue in the near term. Our Trilivy Metabolic Health System is designed as a three-part system. Our foundational phase, Reset, is followed by phase 2 and phase 3, Refine and Renew, respectively. These will support clients in maintaining their progress over time and ultimately help them to achieve optimal metabolic health.
Refine is designed to improve metabolic flexibility and refine body composition, with the overall goal to help enhance metabolism through better fuel use, leading to less fat storage and more muscle mass. The Renew phase is focused on optimizing metabolic health for long-term vitality. For our coaches, they provide additional tools to help support long-term client engagement with the Trilivy Metabolic System. The energy we saw at our sold-out convention in July has carried through this quarter. We are seeing coaches embrace the new brand and products enthusiastically, and we are hearing from them that their conversations with clients increasingly center on metabolic health markers like visceral fat and lean mass. That shift in how our coaches describe what we do is an important part of what makes Trilivy different. Trilivy is giving our coaches something new to talk about, as well as a clearer way to talk about it.
Medifast's work is built on more than 45 years of clinical and scientific heritage. It is that understanding that has led us to Metabolic Synchronization, our proprietary science focused on burning fat, preserving lean muscle, and protecting metabolic health. In an independent clinical study, our Reset 5 & 1 Plan reduced visceral fat by 14% while retaining 98% of lean mass over 16 weeks. Reset Fuelings are the first products to fully use our MetaVantage technology platform, a set of proprietary ingredient formulas designed to optimize metabolic health. The MetaVantage Reset formula helps unlock key metabolic pathways, reducing waist circumference while also supporting normal fat metabolism and healthy insulin. Since the new Trilivy brand and Reset launch in August, MetaVantage has been well received. Early feedback indicates strong interest in the new formula and its role in supporting the full spectrum of metabolic health.
We are continuing to monitor results and coach feedback to determine the impact of launch, but preliminary data indicates fast adoption of our new Trilivy Reset products, with 95% of our active earning coaches in September already offering the line to clients. We believe that this product line will extend our ability to meet the needs of an expanded set of clients and deepen our differentiation in a crowded market. Metabolic health is a large global business opportunity. Key members of our Medifast Metabolic Health Institute recently attended McKinsey and Stanford Medicine's Metabolic Health Business Building Summit 2026, where panelists sized the existing metabolic health market at $12 trillion, with an additional $16 trillion in prevention and optimization that is still largely untapped. The panelists expect that the biggest returns will go to companies that build ecosystems and business models, not just new interventions.
Our own view of the market opportunity supports this. More than 90% of U.S. adults are metabolically unhealthy, and we see similar issues around the globe. Our survey of more than 1,000 U.S. adults conducted last September shows that nearly 94% of Americans are concerned about at least one aspect of their metabolic health, and 85% believe metabolic dysfunction can be reversed. Yet 80% say they have limited understanding of what metabolic health means. That gap between concern and understanding is an area of opportunity for our coaches to educate and support. GLP-1 medications continue to accelerate interest in metabolic health. Our view is that long-lasting and sustainable results depend on lifestyle change, nutrition, support, and coaching in addition to the medications, and that the businesses that win will be capable of providing an offer that works alongside them rather than competing with them.
Weight loss remains important, but the quality of the weight lost matters more than ever. That means preserving lean mass, protecting muscle, and over time, building it. Our three-phase Trilivy system is designed to do exactly that, supporting people across the entire spectrum of their health journey, whether they are on medication, transitioning off it, or never started. One of the clearest signs of confidence in our direction this quarter comes from further developments in the field. This company was built on the belief of our Founder of the Mission and Independent Trilivy Coach, Dr. Wayne Scott Andersen, who, after leaving his medical practice as a critical care physician, dedicated himself to a new mission of lifelong transformation. He invested capital into the business but also brought incredible energy to the mission, as well as deep trust in the power of people to carry that mission into the world.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
5 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
